200 filings
6-K
SLGL
Sol-Gel Technologies Ltd
16 May 24
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to
6:15am
424B3
SLGL
Sol-Gel Technologies Ltd
4 Apr 24
Prospectus supplement
9:05am
EFFECT
SLGL
Sol-Gel Technologies Ltd
2 Apr 24
Notice of effectiveness
12:15am
6-K
SLGL
Sol-Gel Technologies Ltd
1 Apr 24
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to
7:15am
POS AM
SLGL
Sol-Gel Technologies Ltd
20 Mar 24
Prospectus update (post-effective amendment)
4:05pm
6-K
m8rbll tla8n
13 Mar 24
Sol-Gel Reports Full-Year 2023 Financial Results and 2023 - Corporate Highlights and Recent Developments
8:34am
6-K
m7i3298
6 Mar 24
Important Notice to Shareholders Who Are United States Persons
8:29am
6-K
8zvzvhvo91d436acn
29 Feb 24
Current report (foreign)
8:07am
6-K
h87jpagh9v5401arm2
23 Jan 24
Current report (foreign)
6:49am
6-K
mco uhaj7wuhezdtmxi8
17 Jan 24
Current report (foreign)
4:05pm
6-K
1ops5fb2l
30 Nov 23
Current report (foreign)
7:10am
6-K
x2gt787d6dzvl
20 Nov 23
Current report (foreign)
8:20am
424B3
oxuys
9 Nov 23
Prospectus supplement
3:41pm
6-K
y6c eyby7nje
9 Nov 23
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:15am
424B3
p3ev82jaohsvwfbfw7fi
10 Aug 23
Prospectus supplement
7:20am
6-K
urgukou
10 Aug 23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:10am
6-K
ol0cub3mkyc
27 Jul 23
Current report (foreign)
4:05pm
6-K/A
sx8wtlyzkvjb23o ix1
20 Jul 23
Current report (foreign) (amended)
6:00am
6-K
0t53wjf
21 Jun 23
Notice of Annual Meeting of Shareholders
9:38am